Centre Hospitalier Universitaire De Dijon — Sponsor Intelligence | 21 EU Trials

Filter these 21 trials by condition, phase, country and more.

Open in Search →

21 Registered trials

13 Recruiting

7 Completed trials

2 Countries active

32 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I (Other)

Phase III: 13 Phase II: 4 Phase I/II: 1 Phase IV: 1 Phase I (Other): 2

Oversight events:

1 temporary halt 1 corrective measure across 2 trials

View oversight register →

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Adenocarcinoma of colon 1 Macular telangiectasia 1 Idiopathic pulmonary fibrosis 1 Giant cell arteritis 1 Colon cancer 1 Neurogenic bladder 1

Top IMPs

FLUOROURACIL 2 OXALIPLATIN 2 SODIUM CHLORIDE 2 TOCILIZUMAB 2 ACETYLSALICYLIC ACID 1 AFLIBERCEPT 1 APIXABAN 1 ARGIPRESSIN 1 BEVACIZUMAB 1 CAPECITABINE 1 CISPLATIN 1 D,L-LYSINE ACETYLSALICYLATE 1

All trials

21 total

Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial Pending

2024-510811-32-00 Phase III 1 country ACETYLSALICYLIC ACID; D,L-LYSINE ACETYLSALICYLATE; SODIUM CHLORIDE
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting

2023-505486-92-00 Phase II 2 countries
PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with … Recruiting

2023-505046-26-00 Phase III 1 country BEVACIZUMAB; TRIFLURIDINE, TIPIRACIL
Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine-refractory vasoplegic … Recruiting

2024-516639-28-00 Phase III 1 country ARGIPRESSIN; SODIUM CHLORIDE
A pilot, multicentre, controlled, open-label study evaluating 24 months of lithium carbonate treatment in patients with TBR1-related neuroco… Recruiting

2024-513955-34-00 Phase I/II 1 country LITHIUM CARBONATE
PRODIGE 90 - FFCD 22024 - PREDIR-NEOREC - Neoadjuvant dostarlimab with short course radiotherapy in a watch-and-wait strategy for microsatel… Recruiting

2024-510772-20-00 Phase II 1 country DOSTARLIMAB
Multicentre randomised double-blind superiority trial with a roll-over phase to evaluate the efficacy of OM-89 vs placebo in reducing antibi… Recruiting

2024-512595-35-00 Phase III 1 country E.COLI POLYSACCHARIDE
FIRST LINE CHEMOTHERAPY FOR METASTATIC GASTRO ENTERO PANCREATIC NEUROENDOCRINE CARCINOMA Recruiting

2024-515300-39-00 Phase II 1 country CISPLATIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPL…
TOLEDDO: Effect of weekly GLP1 agonist treatment in "double diabetes": a randomized, open-label study Recruiting

2024-514906-30-00 Phase III 1 country SEMAGLUTIDE
PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Phase III 1 country CAPECITABINE
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 Phase III 1 country FLUOROURACIL; OXALIPLATIN
PRODIGE 87 FOXTROT II : Personalising and refining neo-adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly … Recruiting

2023-505214-23-00 Phase III 1 country
API-AHAI - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a P… Recruiting

2024-513191-17-00 Phase II 1 country APIXABAN
Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema Recruiting

2024-513983-24-00 Phase IV 1 country DEXAMETHASONE; FLUOCINOLONE ACETONIDE
Evaluation of the efficacy and safety of drug treatment in familial polycythemia associated with an EPO gene mutation: a multicentre, open-l… Ended

2025-521906-16-00 Phase I (Other) 1 country
PRODIGE 33 - BALLAD - Phase III study to evaluate the benefit of adjuvant chemotherapy in small bowel adenocarcinoma. Ended

2024-515299-11-00 Phase III 1 country
TocilizuMab discontinuAtion in GIant Cell Arteritis Ended

2023-505515-21-00 Phase III 1 country TOCILIZUMAB
MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Ended

2024-512269-14-00 Phase III 1 country PREDNISONE; TOCILIZUMAB
Benefit of a flash dose of corticosteroids in digestive surgical oncology: a randomized, double blind, placebo-controlled trial Ended

2024-513728-40-00 Phase III 1 country METHYLPREDNISOLONE HEMISUCCINATE; METHYLPREDNISOLONE HYDROGEN SUCCINATE
Evaluation of the value of 18F-Fluoromisonidazole (18F-FMISO) positron emission tomography hypoxia imaging in idiopathic pulmonary fibrosis … Ended

2024-515303-19-00 Phase I (Other) 1 country
Comparative multicenter randomized study of aflibercept versus placebo in macular telangiectasia type 1 Ended

2024-511885-35-00 Phase III 1 country AFLIBERCEPT

Showing 1–21 of 21 trials

← All sponsors A–Z